Navigation Links
B. Braun Obtains Permanent Injunction
Date:5/4/2011

BETHLEHEM, Pa., May 4, 2011 /PRNewswire/ -- Germany-based medical device manufacturer B. Braun Melsungen AG and its U.S. subsidiary B. Braun Medical Inc. (B. Braun) announced today that the company succeeded in obtaining a permanent injunction in its patent infringement case against Japan's Terumo Corporation and its U.S. subsidiary Terumo Medical Corporation.

(Logo:  http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

On April 21, 2011, the U.S. District Court for the District of Delaware granted an immediate and permanent order, stopping Japan's Terumo Corporation and its U.S. subsidiary Terumo Medical Corporation from selling, or offering to sell, the Surshield® Safety IV Catheter in the acute care market, and precluding Terumo from bidding against B. Braun on expiring GPO contracts. Terumo will be permitted to continue selling the Surshield Safety IV Catheter into the alternative care market until June 1, 2012 after which it cannot make, sell, use or offer the Surshield Safety Catheter in the U.S.  B. Braun will seek damages and other relief for Terumo's infringement.

B. Braun's win follows a previous verdict awarded in November 2010, confirming the validity of an infringed claim of B. Braun's 2007 patent (U.S. Patent 7,264,613) for its Introcan Safety® IV Catheter.

About B. Braun's Introcan Safety® IV Catheter

B. Braun's Introcan Safety® IV Catheter, a passive, fully automatic safety device, designed to help protect against accidental needlestick injuries (NSIs). NSIs and other sharps injuries expose hundreds of thousands of healthcare providers each year to serious blood borne pathogens like hepatitis C and HIV. With the Introcan Safety® IV Catheter, the safety device is activated automatically and cannot be bypassed.

A recent landmark study conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants) of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices like B. Braun's Introcan Safety® IV Catheter offer significantly better protection against NSIs than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

For more information about B. Braun's Introcan Safety® IV Catheter visit http://introcansafety.bbraunusa.com.  

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy,

B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


'/>"/>
SOURCE B. Braun
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Offers Wound Patients a New Over-the-Counter Wound Management Gel - Prontosan®
2. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
3. B. Braun Wins Third Consecutive Safety IV Catheters Contract Award from Premier, Inc.
4. FDA-Approved Cefepime Now Available for Use in B. Brauns DUPLEX® System
5. B. Braun Customers Gain Premier Access to Zynx Health Device Networks Evidence-based, Customizable Drug Library Program
6. B. Braun Large Volume Heparin Infusion Solutions Now Available
7. New Technology Center Increases B. Brauns Infusion Pump Capacity
8. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
9. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
10. B. Braun Renal Therapies Division Announces Availability of Adimea
11. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... 28, 2017  Medeon Biodesign, Inc., a ... pleased to announce that the Company led and ... Orthopedics, Inc., a San Jose, CA ... for orthopedic extremity applications.  The ... primarily due to procedure volume growth, lifestyle influences ...
(Date:3/27/2017)... Israel , March 27, 2017 ... THXBY), a specialty clinical-stage pharmaceutical company specializing in the development ... its public offering in the United ... (ADSs), each ADS representing 40 ordinary shares of ... ADS. In addition, Therapix has granted the underwriters ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... San Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... million people suffering from acne, access to quality care can be limited while the ... skincare company that offers customized prescription acne care for every customer online, today released ...
(Date:3/28/2017)... ... , ... The Executives, Staff & Clients of MGE: Management Experts joined forces ... Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. Petersburg Office. ... number 14 internationally in literacy. Statistically, a direct relation can be a found between ...
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Camp Conference in Atlantic City March 13-16, was a busy spot this year. ... professional staff discussed strategies for preventing outbreaks among camp communities during the upcoming ...
Breaking Medicine News(10 mins):